• Like
  • Save

Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Q1 2013 Investor Conference Call Presentation Charts

on

  • 551 views

Q1 2013 Investor Conference Call Presentation Charts

Q1 2013 Investor Conference Call Presentation Charts

Statistics

Views

Total Views
551
Views on SlideShare
551
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Q1 2013 Investor Conference Call Presentation Charts Q1 2013 Investor Conference Call Presentation Charts Presentation Transcript

    • Q1 2013 ResultsInvestor Conference CallApril 25, 2013 / Marijn Dekkers, CEO
    • DisclaimerThis presentation may contain forward-looking statements based on currentassumptions and forecasts made by Bayer Group or subgroup management.Various known and unknown risks, uncertainties and other factors could lead tomaterial differences between the actual future results, financial situation,development or performance of the company and the estimates given here.These factors include those discussed in Bayer’s public reports which areavailable on the Bayer website at www.bayer.com.The company assumes no liability whatsoever to update these forward-lookingstatements or to conform them to future events or developments.• Q1 2013 Investor Conference Call • Marijn DekkersPage 2
    • Page 3Q1 2013 – LifeScience Businesses Off To AGood Start HealthCare benefits from successful launch of new products and stronggrowth in Consumer Care CropScience continues to grow profitably in ongoing favorable marketenvironment Cost pressure at MaterialScience resulted in earnings performancebelow expectations Group sales organically +4%; reported EBIT +9%; adjusted* EBITDAat prior-year level Full-year 2013 Group outlook confirmed• Q1 2013 Investor Conference Call • Marijn Dekkers*before special items
    • Page 4EBITin € million+9%1,7711,631Salesin € million% currency & portfolio adj.+4%10,26610,054EBITDAadjusted**in € million0%2,4532,443Core EPSin €+2%1.701.67*Prior-year figures restated.**before special itemsQ1’13Q1’12* Q1’13Q1’12* Q1’13Q1’12* Q1’13Q1’12*Q1 2013 – Total Group:LifeSciences Commence Positively• Q1 2013 Investor Conference Call • Marijn Dekkers
    • Regional Performance - Growth Led By USAAnd Emerging EconomiesPage 5Africa &Middle EastEasternEuropeEmerging EconomiesEmergingEconomies¹+7%Others²+8%USA+8%Western Europe-3%Q1 2013 Group Sales by RegionGroup €10,266m; +4%~1,000+8%~1,400+8%~400-7%~700+13%¹ Emerging economies include: Latin America, Asia w/o Japan, Australia,New Zealand, Africa and Middle East incl. Turkey, Eastern Europe² Others = Japan, Australia, New Zealand, Canada³ Emerging Asia = Asia w/o Japan, Australia, New ZealandIn € million, ∆% yoy Fx adjusted34%12%32%22%LatinAmericaEmergingAsia³• Q1 2013 Investor Conference Call • Marijn Dekkers
    • Q1 2013 –Cash Flow And Net Debt DevelopmentPage 6+€491m 7.5GCF oFCF1,807Invest-ments365 (38)∆y-o-y +13% -100%NCF327+38% +43%Dec 31, 2012 Mar 31, 20137.0Q1 2013 Cash Flow Net Debt DevelopmentCash Flow in € million, Net Debt in € billion• Q1 2013 Investor Conference Call • Marijn Dekkers
    • Q1 2013 – HealthCare: New Products andConsumer Care Drive GrowthPage 7*before special itemsQ1 2013 Sales Earnings1Pharma+2% (+5%)ConsumerHealth+3% (+5%)36%HealthCare €4,443m; +2% (+5%)2,5641,879Price+1%Volume+4%Fx-3%Portfolio0%In € million, ∆% yoy, () = Fx & portf. adjustedQ1‘12 Q1‘13 Q1‘12 Q1‘13740832441 445+12%+1%1,1811,277 +8%341 +1%861953 +11%520343Adj.EBITDA*Adj.EBIT*610 +17%• Q1 2013 Investor Conference Call • Marijn Dekkers 1 Prior-year figures restated.
    • Q1 2013 – CropScience: ContinuouslyStrongIn Favorable Market EnvironmentPage 8Crop Protection+9% (+11%)EnvironmentalScience-12% (-10%)Seeds+1% (0%)Q1 2013 Sales Earnings1In € million, ∆% yoy, () = Fx & portf. adjustedCropScience €2,764m; +6% (+7%)Price+3%Volume+4%Fx-2%Portfolio0%2,111Q1‘12 Q1‘13 Q1‘12 Q1‘139841,081 +10%864969 +12%Adj.EBITDA*Adj.EBIT*164489• Q1 2013 Investor Conference Call • Marijn Dekkers*before special items1 Prior-year figures restated.
    • Q1 2013 – MaterialScience: Cost PressurePrevented A Better PerformancePage 9**CAS: Coatings, Adhesives, Specialties *** IO: Industrial OperationsPolyurethanes+3% (+4%)Polycarbonates-6% (-6%)CAS**-3% (-3%)Q1 2013 Sales Earnings1In € million, ∆% yoy, () = Fx & portf. adjusted*before special itemsMaterialScience €2,775m; +0% (+0%)Price+4%Volume-4%Fx-1%Portfolio0%1,469663IO***+0% (+1%)Q1‘12 Q1‘13 Q1‘12 Q1‘13Adj.EBITDA*Adj.EBIT*279204 -27%12143 -65%467176• Q1 2013 Investor Conference Call • Marijn Dekkers 1 Prior-year figures restated.
    • FY 2013 Group Outlook ConfirmedPage 1020121 ∆ vs. 2011 2013ESales €39.7bn +5%+4-5% to~€41bn*adj. EBITDA €8.3bn +9%mid-single-digit %increaseCore EPS €5.30 +10%high-single-digit %increaseSales ∆ Fx and portfolio adjusted, EBITDA before special items*Assuming Fx rate of $1.29 per €Outlook depends on specific planning assumptions as detailed in the Annual Report• Q1 2013 Investor Conference Call • Marijn Dekkers1 2012 figures restated.
    • Q1 2013 ResultsInvestor Conference CallApril 25, 2013 / Marijn Dekkers, CEO